載入...
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer
Androgen receptor (AR) is an attractive target in breast cancer because of its frequent expression in all the molecular subtypes, especially in estrogen receptor (ER)-positive luminal breast cancers. We have previously shown a role for AR overexpression in tamoxifen resistance. We engineered ER-posi...
Na minha lista:
| 發表在: | Breast Cancer Res Treat |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4337991/ https://ncbi.nlm.nih.gov/pubmed/25178514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3082-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|